Organogenesis Holdings (ORGO) Non-Current Debt (2017 - 2024)

Organogenesis Holdings' Non-Current Debt history runs 8 years deep, the most recent figure standing at $56.2 million for Q3 2024.

• In Q3 2024, Non-Current Debt fell 9.6% year-over-year to $56.2 million; the TTM figure through Sep 2024 stood at $56.2 million (down 9.6% YoY), while the FY2023 annual figure was $60.7 million, down 8.28% from the prior year.
• Non-Current Debt was $56.2 million for Q3 2024 at Organogenesis Holdings, down from $57.7 million in the prior quarter.
• In the past five years, Non-Current Debt ranged from a high of $70.8 million in Q4 2021 to a low of $10.0 million in Q1 2020.
• Historically, Non-Current Debt has averaged $51.6 million across 5 years, with a median of $60.1 million in 2023.
• The sharpest annual moves came in 2020 and 2021: Non-Current Debt tumbled 79.85% in 2020, then surged 607.69% in 2021.
• A 5-year view of Non-Current Debt shows it stood at $10.0 million in 2020, then soared by 607.69% to $70.8 million in 2021, then fell by 6.41% to $66.2 million in 2022, then dropped by 8.28% to $60.7 million in 2023, then dropped by 7.56% to $56.2 million in 2024.
• The last three Non-Current Debt figures came in at $56.2 million (Q3 2024), $57.7 million (Q2 2024), and $59.4 million (Q1 2024), per Business Quant data.